225 related articles for article (PubMed ID: 21542009)
1. APPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner.
Cui S; Xiong F; Hong Y; Jung JU; Li XS; Liu JZ; Yan R; Mei L; Feng X; Xiong WC
J Bone Miner Res; 2011 May; 26(5):1084-98. PubMed ID: 21542009
[TBL] [Abstract][Full Text] [Related]
2. Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine.
Xia WF; Jung JU; Shun C; Xiong S; Xiong L; Shi XM; Mei L; Xiong WC
J Bone Miner Res; 2013 Oct; 28(10):2122-35. PubMed ID: 23649480
[TBL] [Abstract][Full Text] [Related]
3. Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling.
Li S; Yang B; Teguh D; Zhou L; Xu J; Rong L
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27735865
[TBL] [Abstract][Full Text] [Related]
4. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
5. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.
Cho HJ; Son SM; Jin SM; Hong HS; Shin DH; Kim SJ; Huh K; Mook-Jung I
FASEB J; 2009 Aug; 23(8):2639-49. PubMed ID: 19332646
[TBL] [Abstract][Full Text] [Related]
6. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis.
Yoshida T; Flegler A; Kozlov A; Stern PH
J Cell Biochem; 2009 Aug; 107(5):917-25. PubMed ID: 19415676
[TBL] [Abstract][Full Text] [Related]
7. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.
Wang L; Zhao R; Shi X; Wei T; Halloran BP; Clark DJ; Jacobs CR; Kingery WS
Bone; 2009 Aug; 45(2):309-20. PubMed ID: 19379851
[TBL] [Abstract][Full Text] [Related]
8. Iron Chelation Inhibits Osteoclastic Differentiation In Vitro and in Tg2576 Mouse Model of Alzheimer's Disease.
Guo JP; Pan JX; Xiong L; Xia WF; Cui S; Xiong WC
PLoS One; 2015; 10(11):e0139395. PubMed ID: 26575486
[TBL] [Abstract][Full Text] [Related]
9. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
10. CXCR4
Goto Y; Aoyama M; Sekiya T; Kakita H; Waguri-Nagaya Y; Miyazawa K; Asai K; Goto S
Stem Cells; 2016 Nov; 34(11):2733-2743. PubMed ID: 27339271
[TBL] [Abstract][Full Text] [Related]
11. Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice.
Pierroz DD; Rufo A; Bianchi EN; Glatt V; Capulli M; Rucci N; Cavat F; Rizzoli R; Teti A; Bouxsein ML; Ferrari SL
J Bone Miner Res; 2009 May; 24(5):775-84. PubMed ID: 19113915
[TBL] [Abstract][Full Text] [Related]
12. Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction.
Origlia N; Righi M; Capsoni S; Cattaneo A; Fang F; Stern DM; Chen JX; Schmidt AM; Arancio O; Yan SD; Domenici L
J Neurosci; 2008 Mar; 28(13):3521-30. PubMed ID: 18367618
[TBL] [Abstract][Full Text] [Related]
13. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
[TBL] [Abstract][Full Text] [Related]
15. An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease.
Webster SJ; Mruthinti S; Hill WD; Buccafusco JJ; Terry AV
Neuromolecular Med; 2012 Jun; 14(2):119-30. PubMed ID: 22415896
[TBL] [Abstract][Full Text] [Related]
16. Coumarin Ameliorates Impaired Bone Turnover by Inhibiting the Formation of Advanced Glycation End Products in Diabetic Osteoblasts and Osteoclasts.
Lee EJ; Kang MK; Kim YH; Kim DY; Oh H; Kim SI; Oh SY; Na W; Kang YH
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32679814
[TBL] [Abstract][Full Text] [Related]
17. Glycation exacerbates the neuronal toxicity of β-amyloid.
Li XH; Du LL; Cheng XS; Jiang X; Zhang Y; Lv BL; Liu R; Wang JZ; Zhou XW
Cell Death Dis; 2013 Jun; 4(6):e673. PubMed ID: 23764854
[TBL] [Abstract][Full Text] [Related]
18. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
[TBL] [Abstract][Full Text] [Related]
19. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
Han SY; Lee KH; Kim YK
Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 expression and release by bone cells.
Charoonpatrapong K; Shah R; Robling AG; Alvarez M; Clapp DW; Chen S; Kopp RP; Pavalko FM; Yu J; Bidwell JP
J Cell Physiol; 2006 May; 207(2):480-90. PubMed ID: 16419037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
